Biermasz NR - Search Results

1

Lanreotide versus placebo for tumour reduction in patients with a ⁶⁸Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): a randomised, multicentre, phase 3 trial with blinded outcome assessment.

Boertien TM, Drent ML, Booij J, Majoie CBLM, Stokkel MPM, Hoogmoed J, Pereira AM, Biermasz NR, Simsek S, Veldman RG, Weterings AJ, Vink JM, Tanck MWT, Fliers E, Bisschop PH. Boertien TM, et al. Among authors: biermasz nr. Lancet Reg Health Eur. 2024 May 13;42:100923. doi: 10.1016/j.lanepe.2024.100923. eCollection 2024 Jul. Lancet Reg Health Eur. 2024. PMID: 39070749 Free PMC article.

2

Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass.

Smit JW, Janssen YJ, Lamb HJ, van der Wall EE, Stokkel MP, Viergever E, Biermasz NR, Bax JJ, Vliegen HW, de Roos A, Romijn JA, Roelfsema F. Smit JW, et al. Among authors: biermasz nr. J Clin Endocrinol Metab. 2001 Oct;86(10):4638-43. doi: 10.1210/jcem.86.10.7832. J Clin Endocrinol Metab. 2001. PMID: 11600518 Clinical Trial.

3

Octreotide represses secretory-burst mass and nonpulsatile secretion but does not restore event frequency or orderly GH secretion in acromegaly.

Biermasz NR, Pereira AM, Frölich M, Romijn JA, Veldhuis JD, Roelfsema F. Biermasz NR, et al. Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E25-30. doi: 10.1152/ajpendo.00230.2003. Epub 2003 Sep 23. Am J Physiol Endocrinol Metab. 2004. PMID: 14506078 Free article. Clinical Trial.

4

Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease.

Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA. Pereira AM, et al. Among authors: biermasz nr. J Clin Endocrinol Metab. 2003 Dec;88(12):5858-64. doi: 10.1210/jc.2003-030751. J Clin Endocrinol Metab. 2003. PMID: 14671181

5

Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients.

van Thiel SW, Romijn JA, Biermasz NR, Ballieux BE, Frölich M, Smit JW, Corssmit EP, Roelfsema F, Pereira AM. van Thiel SW, et al. Among authors: biermasz nr. Eur J Endocrinol. 2004 Apr;150(4):489-95. doi: 10.1530/eje.0.1500489. Eur J Endocrinol. 2004. PMID: 15080778 Clinical Trial.

6

Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.

Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F. Biermasz NR, et al. Clin Endocrinol (Oxf). 2004 May;60(5):568-75. doi: 10.1111/j.1365-2265.2004.02021.x. Clin Endocrinol (Oxf). 2004. PMID: 15104559 Clinical Trial.

7

Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.

Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA, Roelfsema F. Biermasz NR, et al. J Clin Endocrinol Metab. 2004 Jun;89(6):2789-96. doi: 10.1210/jc.2003-032041. J Clin Endocrinol Metab. 2004. PMID: 15181059

8

Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery.

Zirkzee EJ, Corssmit EP, Biermasz NR, Brouwer PA, Wiggers-De Bruine FT, Kroft LJ, Van Buchem MA, Roelfsema F, Pereira AM, Smit JW, Romijn JA. Zirkzee EJ, et al. Among authors: biermasz nr. J Clin Endocrinol Metab. 2004 Sep;89(9):4320-4. doi: 10.1210/jc.2003-032141. J Clin Endocrinol Metab. 2004. PMID: 15356027

9

Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.

Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F. Biermasz NR, et al. J Clin Endocrinol Metab. 2004 Nov;89(11):5369-76. doi: 10.1210/jc.2004-0669. J Clin Endocrinol Metab. 2004. PMID: 15531483

10

Pharmacologic therapies for acromegaly: a review of their effects on glucose metabolism and insulin resistance.

Pereira AM, Biermasz NR, Roelfsema F, Romijn JA. Pereira AM, et al. Among authors: biermasz nr. Treat Endocrinol. 2005;4(1):43-53. doi: 10.2165/00024677-200504010-00005. Treat Endocrinol. 2005. PMID: 15649100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters